Keyphrases
Novel Antibodies
100%
Peptide Epitopes
100%
MUC16
100%
Epitope
44%
Glycoform
33%
Immunodominant
22%
Tandem Repeats
22%
Cancer-related
11%
Glycosylation Site
11%
Well-defined
11%
Escherichia Coli
11%
Benign Lesion
11%
Monoclonal Antibody
11%
Diagnostic Interventions
11%
Glycosylation
11%
Immunogen
11%
Mucin
11%
Prognostic Biomarker
11%
Biomarker Testing
11%
Precancerous Lesions
11%
Vaccine Design
11%
Serum IgG
11%
Repeat Region
11%
Ovarian Carcinoma
11%
Immunodetection
11%
Promising Target
11%
IgG Response
11%
Short Peptides
11%
Immunochemistry
11%
O-glycosylation Site
11%
Linear Peptide
11%
Immunotherapeutic Intervention
11%
Immunology and Microbiology
Epitope
100%
Monoclonal Antibody
100%
MUC16
100%
Monospecific Antibody
33%
Vaccine Efficacy
33%
Tandem Repeat
22%
Glycosylation
22%
Escherichia coli
11%
Mouse
11%
Antigen
11%
Mucin
11%
Immunochemistry
11%
Biochemistry, Genetics and Molecular Biology
Monoclonal Antibody
100%
MUC16
100%
Monospecific Antibody
33%
Glycosylation
22%
Tandem Repeat
22%
Mouse
11%
Escherichia coli
11%
Mucin
11%
Tumor Marker
11%